T3 · Product exporter position

China exports of Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) (HS 300390)

See where China stands in medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale): export scale, destination breadth, market position, growth, and reported trade history.

Explore this product View destinations

Exporter CHNHS6 300390Latest year 2024Rapid growth

Latest exports

$519.5MLatest observed lane total

Destination markets

139Reported active markets

Three-year growth

+10.8%Annualized change

Destination HHI

1,041Destination concentration

Weighted share

31.1%Reported market position

Exporter evidence

How strong is China in Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)?

Reported exporter totals and calculated indicators for HS 300390. Values retain their observed coverage period.

Exporter scale

Latest exports$519.5M

Current 2024 exports$518.3M

Three-year average$515.9M

Historical peak$755.1M

Market position

Active destinations139

Destination HHI1,041

Weighted share31.1%

Share change+1.1 pp

Competitiveness

Three-year growth+10.8%

Volatility1.1

Maximum drawdown82.1%

TrendRapid growth

Measure	Value	What it describes
Exporter	China	Country represented by this profile
Latest observed exports	$519.5M	Sum of latest observed destination-lane values
Current 2024 exports	$518.3M	Common-year comparison where reported
Three-year growth	+10.8%	Annualized change in exporter totals
Five-year growth	+9.7%	Annualized change in exporter totals
Leading destination	IND	Destination with the largest observed export value
Leading destination share	24.4%	Share of observed exporter totals
Destination concentration	1,041	HHI across destination markets
Weighted share change	+1.1 pp	Value-weighted latest change in market share
Limited-history lanes	9.9%	Share of lanes with shorter history

Destination markets

Where does China sell medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)?

Leading destination observations ranked by reported export value, with market position and access context.

Destination	Latest exports	Market share	Growth	Access	Signal
India	$126.9M	71.1%	+38.5%	0.5% tariff	Accelerating
USA, Puerto Rico and US Virgin Islands	$76.6M	4.2%	-2.3%	0% tariff	Growing
Japan	$57.6M	15%	+11.2%	0% tariff	Growing
Republic of Korea	$25.0M	28.9%	+27.8%	FTA reported	Growing
Brazil	$23.7M	22.2%	+12.7%	0.3% tariff	Accelerating

Destination

India

Latest exports: $126.9M
Market share: 71.1%
Growth: +38.5%
Access: 0.5% tariff
Signal: Accelerating

Destination

USA, Puerto Rico and US Virgin Islands

Latest exports: $76.6M
Market share: 4.2%
Growth: -2.3%
Access: 0% tariff
Signal: Growing

Destination

Japan

Latest exports: $57.6M
Market share: 15%
Growth: +11.2%
Access: 0% tariff
Signal: Growing

Destination

Republic of Korea

Latest exports: $25.0M
Market share: 28.9%
Growth: +27.8%
Access: FTA reported
Signal: Growing

Destination

Brazil

Latest exports: $23.7M
Market share: 22.2%
Growth: +12.7%
Access: 0.3% tariff
Signal: Accelerating

Price intelligence

How does China's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

Ireland: $4.9M / ton.

Lowest reported price

Croatia: $28.8 / ton.

Median price

$13.3K / ton across reported markets.

Export trend

Reported export history

Annual observations for China and HS 300390 where available.

Year	Exports	Year-on-year change	Active destinations
2010	$184.4M	+17.7%	126
2011	$186.4M	+1.1%	124
2012	$213.4M	+14.5%	136
2013	$217.7M	+2%	134
2014	$225.0M	+3.4%	139
2015	$263.0M	+16.9%	142
2016	$259.9M	-1.2%	146
2017	$259.4M	-0.2%	138
2018	$305.8M	+17.9%	131
2019	$325.8M	+6.5%	144
2020	$366.6M	+12.5%	145
2021	$380.9M	+3.9%	134
2022	$513.7M	+34.9%	146
2023	$515.7M	+0.4%	146
2024	$518.3M	+0.5%	139

Exporter context

China economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300390.

China has reported exports of $3.5T and a trade balance of $1.2T in 2024.

Available structural indicators include 34.6% trade openness, 44.5% investment, and 270 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about China medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.